Visual-spatial and Visual-perceptual Disorders Following Cerebellar Strokes
NCT ID: NCT04920461
Last Updated: 2021-06-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
42 participants
INTERVENTIONAL
2020-04-16
2021-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Verticality Perception in Stroke Patients
NCT02184923
Time Course of a Misperception of Verticality and Its Characteristics in Post-stroke Participants
NCT05978596
REEDUCATION OF OLFACTORY DISORDERS AFTER A CEREBRAL VASCULAR ACCIDENT IN ADULTS
NCT04703218
HAptic Neurofeedback Design for Stroke
NCT04130711
Proprioceptive Deficits and Anomalies in Movement-error Processing in Chronic Stroke Patients
NCT02881736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Additional MRI sequences
Additional MRI sequences
Additional MRI sequences (3D T2 SPACE sequence, 4/5 minutes approximatively)
Neuropsychological assessment
Neurovisual function assessed with neuropsychological tests
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Additional MRI sequences
Additional MRI sequences (3D T2 SPACE sequence, 4/5 minutes approximatively)
Neuropsychological assessment
Neurovisual function assessed with neuropsychological tests
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being able to pass initial neuropsychological tests within 10 days after stroke
Exclusion Criteria
* Chronic alcoholism
* MRI contraindication.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eloi MAGNIN, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU de Besançon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Besançon
Besançon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/2019/423
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.